Board of Directors

Douglas W. Jamison


Chairman of the Board & Chief Executive Officer Douglas Jamison

Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009; as President and Chief Operating Officer from January 2005 to December 2008; as Treasurer from March 2005 to May 2008; as a Managing Director from January 2004 to July 2016; as Chief Financial Officer from January 2005 to December 2007; and as Vice President from September 2002 to December 2004. He has been a member of our Board of Directors since May 2007. Since January 2009, he has served as Chairman and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the Company, since 2005, he has served as a Director; and from January 2005 to December 2008 he served as President . From 1998 to 2002, Mr. Jamison worked as a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property for the University of Utah. This included assessing technologies in both the biological sciences and the physical sciences, working with patent attorneys to develop patent protection, and developing and marketing these technologies with industry. He is a Co-Editor-in-Chief, Journal of Nanotechnology Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association and a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board. He was graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).

Portfolio responsibilities: ABS Materials, HZO, Metabolon, Product Water Absorbents and ProMuc.

Committee Chair Chair of the Executive Committee

W. DILLAWAY AYRES, JR.


Director since 2006

Mr. Ayres is Chief Operating Officer of Cold Spring Harbor Laboratory, a research and educational institution in the biological sciences since November 2000. Prior to joining Cold Spring Harbor Laboratory in 1998, Mr. Ayres had a 20-year business career during which he worked as a corporate executive, investment banker and entrepreneur. In 1996, he co-founded Business & Trade Network, Inc., a business-to-business, venture capital-backed internet company. Prior to that he worked for five years as a Managing Director of Veronis, Suhler & Associates, a boutique investment banking firm in New York specializing in the media/communications industry. At Veronis, Suhler, he focused on investing the firms's private equity fund. He was graduated from Princeton University (A.B.) and from Columbia University Graduate Shcool of Business (M.B.A. in Finance)

Member Member of the Audit Committee
Committee Chair Chair of the Compensation Committee
Member Member of the Executive Committee
Member Member of the Valuation Committee

PHILLIP A. BAUMAN, M.D.


Director since 1998

Dr. Bauman is a practicing orthopedic surgeon. Since 1999, he has been Senior Attending in Orthopedic Surgery at St. Luke's/Roosevelt Hospital Center in Manhattan and since 2000 has served as an elected member of the Executive Committee of the Medical Board. Since 2005, he has been on the Board of Managers for the Hudson Crossing Surgery Center. Since 1997, he has been Assistant Professor of Orthopedic Surgery at Columbia University and since 1994, a Vice President of Orthopedic Associates of New York. In 1991, he was elected a fellow of the American Academy of Orthopaedic Surgeons. Since 2005, he has consulted for Skyline Venture Partners, a venture capital firm specializing in healthcare companies. He is an active member of the American Orthopaedic Society for Sports Medicine, the American Orthopaedic Foot and Ankle Society, the New York State Society of Orthopaedic Surgeons, the New York State Medical Society and the American Medical Association. He was graduated from Harvard College (A.B.), Harvard University (A.M., Biology) and the College of Physicians and Surgeons at Columbia University (M.D.).

Member Member of the Compensation Committee
Member Member of the Nominating Committee
Member Member of the Valuation Committee

STACY R. BRANDOM


Director since 2014

Since October 2009, Ms. Brandom has been an Executive Vice President and Chief Financial Officer of Trinity Wall Street, an historic Anglican church in lower Manhattan, N.Y.  Prior to joining Trinity Wall Street, she was a Managing Advisor of Brandom Advisors, from 2008 to 2009.  Ms. Brandom served as Chief Financial Officer and Managing Director of Citi Smith Barney from 2005 to 2007.  She held various positions at JPMorgan Chase and its predecessor firms from 1984 to 2005, including Chief Financial Officer of JP Morgan Chase Corporate Sector and Chase Middle Market Group; Head of Strategy and Administration, Corporate Business Service of JP Morgan Chase; Head of Strategy and Administration and Managing Director, Global Investment Banking (Chase); Head of Strategy and Managing Director, Global Bank (Chemical Bank, pre Chase merger).  She is a member of the board of directors of Bridges to Community, a non-governmental organization dedicated to construction projects in Nicaragua, and a member of the board of directors of Westchester Jazz Orchestra.  She was graduated from the University of North Texas (B.B.A.) and the Kellogg School of Business at Northwestern University (M.B.A.). 

Committee Chair Chair of the Audit Committee
Member Member of the Compensation Committee
Member Member of the Executive Committee
Member Member of the Valuation Committee

KEVIN M. RENDINO


Director since 2016

Mr. Rendino  is the President and CEO of RGJ Capital, LLC, a fund focused on investing in securities that are undervalued relative to the future true worth of their underlying assets.  Prior to this, Mr. Rendino served as Portfolio Manager and Managing Director at BlackRock, Inc., where he was head of the Basic Value Equity Group ($10 to $13 billion in assets), as well as being a member of BlackRock’s Leadership Committee.  Mr. Rendino joined BlackRock in 2006, following its merger with Merrill Lynch Investment Managers.  His career began with Merrill Lynch in 1988, where he held various roles, including Managing Director, Portfolio Manager and heading the Basic Value Group.  Mr. Rendino has served on the board of directors of Partners for Health, a public charity based in Montclair, New Jersey since 2012 and has served as its Board Chair since 2014.  Partners for Health’s focus areas include: hunger and homelessness; policy and environmental changes that promote healthy people in healthy places; aging in our communities and mental health.  Mr. Rendino was graduated from the Carroll School of Management at Boston College (B.S.). 

Member Member of the Audit Committee
Member Member of the Compensation Committee
Member Member of the Valuation Committee

CHARLES E. RAMSEY


Director since 2002

Since 1997, Mr. Ramsey has been a consultant in the area of human resources and venture capital. He is a retired founder and principal of Ramsey/Beirne Associates, Inc., an executive search firm that specialized in recruiting top officers for high-technology companies, many of which were backed by venture capital. He is a member of the board of directors and Chairman Emeritus of Bridges to Community, a non-governmental organization dedicated to construction projects in Nicaragua. As Chairman Emeritus, he serves on the Executive, Personnel and Administration and Fund Development Committees. He was graduated from Wittenberg University (B.A.).

Member Member of the Compensation Committee
Member Member of the Executive Committee
Committee Chair Chair of the Nominating Committee
Member Member of the Valuation Committee

RICHARD P. SHANLEY


Director since 2007; Lead Independent Director Since May 2013

From 2001 to 2006, Mr. Shanley was a Partner (now retired) of Deloitte & Touche LLP. From 1976 to 2001, he worked for Eisner LLP and was a partner from 1982 until 2001. During his over 30 years of public accounting experience, he served as lead audit partner on numerous audit engagements for public and private companies and companies making public stock offerings, including those requiring application of Sarbanes-Oxley Section 404. He served as lead audit partner primarily for biotech, pharmaceutical and high-tech companies, including companies enabled by nanotechnology. He has been actively involved on the Biotech Council of New Jersey, the New Jersey Technology Council, the New York Biotechnology Association, the Connecticut Venture Group, the Biotechnology Industry Organization and the NanoBusiness Alliance. He is a member of the board of directors of Redpoint Bio Corporation, a publicly held biotechnology company. He is an active member of the New York State Society of Certified Public Accountants and the American Institute of Certified Public Accountants. He is currently serving his fifth term on the New York State Society of CPA's Professional Ethics Committee and as of June 2009 is chairing that committee. He is a licensed Certified Public Accountant in New York. He was graduated from Fordham University (B.S.) and Long Island University (M.B.A. in Accounting).

Member Member of the Audit Committee
Member Member of the Executive Committee
Member Member of the Nominating Committee
Committee Chair Chair of the Valuation Committee

NASDAQTINY
Price:$1.26
Change-1.56% 0.02
Day High$1.29
Day Low$1.25
Volume59,801

As of 3:54 PM ET on 02/24/17
Quote delayed at least 20 minutes.

More

Corporate Headquarters
1450 Broadway, 24th Floor
New York, NY 10018
Phone: 212 582 0900
Fax: 212 582 9563
admin@hhvc.com

West Coast Office:
530 Lytton Avenue - 2nd Floor
Palo Alto, CA 94301
Phone: 650 617 3386
Fax: 650 617 3201